0

COMBIVIR از شرکت VIIV HLTHCARE

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

COMBIVIR از شرکت VIIV HLTHCARE

New Drug Application (NDA): 020857

Company: VIIV HLTHCARE

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
COMBIVIR LAMIVUDINE; ZIDOVUDINE 150MG;300MG TABLET;ORAL Prescription

AB

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/26/1997 ORIG-1 Approval

Type 4 – New Combination

PRIORITY

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
05/10/2019 SUPPL-34 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020857s034lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/020857Orig1s034ltr.pdf

04/27/2018 SUPPL-33 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020857s033lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/020857Orig1s033ltr.pdf

04/10/2017 SUPPL-32 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020857s032lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/020857Orig1s032ltr.pdf

02/24/2017 SUPPL-31 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020857s031lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/020857Orig1s031ltr.pdf

09/25/2015 SUPPL-30 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/20857s030lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020857Orig1s030ltr.pdf

11/18/2011 SUPPL-28 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020857s028lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020857s028ltr.pdf

10/01/2010 SUPPL-26 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020857s026lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020857s026ltr.pdf

02/02/2009 SUPPL-23 Efficacy-New Patient Population

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020857s023lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/020857s023ltr.pdf

04/23/2007 SUPPL-21 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020857s021lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020857s021ltr.pdf

10/25/2006 SUPPL-20 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020857s020lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020857s020ltr.pdf

06/27/2006 SUPPL-18 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020857s018lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020857s018ltr.pdf

09/29/2004 SUPPL-15 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20857s015lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20857s015ltr.pdf

05/17/2004 SUPPL-14 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20857slr014_combivir_lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20857slr014ltr.pdf

10/08/2002 SUPPL-12 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20857s12lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20857slr012ltr.pdf

09/13/2002 SUPPL-11 Manufacturing (CMC)

Review (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020857_S011_Epivir.pdf

08/09/2002 SUPPL-10 Labeling

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20857slr012lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20857slr009,010ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020857_S010_Combivar.pdf

08/09/2002 SUPPL-9 Labeling

Label (PDF)

Letter (PDF)

Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20857slr012lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20857slr009,010ltr.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/020857_S009_Combivar.pdf

09/29/2000 SUPPL-8 Labeling

Review

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-857s008_Combivir.cfm

02/01/2000 SUPPL-7 Manufacturing (CMC)-Control

Label is not available on this site.

01/21/2000 SUPPL-6 Labeling

Label is not available on this site.

04/12/1999 SUPPL-5 Manufacturing (CMC)-Control

Label is not available on this site.

02/26/1999 SUPPL-4 Manufacturing (CMC)

Label is not available on this site.

03/08/1999 SUPPL-3 Labeling

Label is not available on this site.

07/31/1998 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

02/27/1998 SUPPL-1 Labeling

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
05/10/2019 SUPPL-34

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020857s034lbl.pdf
04/27/2018 SUPPL-33

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/020857s033lbl.pdf
04/10/2017 SUPPL-32

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020857s032lbl.pdf
02/24/2017 SUPPL-31

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020857s031lbl.pdf
09/25/2015 SUPPL-30

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/20857s030lbl.pdf
11/18/2011 SUPPL-28

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020857s028lbl.pdf
10/01/2010 SUPPL-26

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020857s026lbl.pdf
02/02/2009 SUPPL-23

Efficacy-New Patient Population

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020857s023lbl.pdf
04/23/2007 SUPPL-21

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020857s021lbl.pdf
10/25/2006 SUPPL-20

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020857s020lbl.pdf
06/27/2006 SUPPL-18

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020857s018lbl.pdf
09/29/2004 SUPPL-15

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20857s015lbl.pdf
05/17/2004 SUPPL-14

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20857slr014_combivir_lbl.pdf
10/08/2002 SUPPL-12

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20857s12lbl.pdf
08/09/2002 SUPPL-10

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20857slr012lbl.pdf
08/09/2002 SUPPL-9

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20857slr012lbl.pdf

COMBIVIR

TABLET;ORAL; 150MG;300MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
COMBIVIR LAMIVUDINE; ZIDOVUDINE 150MG;300MG TABLET;ORAL Prescription Yes AB 020857 VIIV HLTHCARE
LAMIVUDINE AND ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE 150MG;300MG TABLET;ORAL Prescription No AB 206375 ANDA REPOSITORY
LAMIVUDINE AND ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE 150MG;300MG TABLET;ORAL Prescription No AB 077558 AUROBINDO PHARMA LTD
LAMIVUDINE AND ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE 150MG;300MG TABLET;ORAL Prescription No AB 202418 AUROBINDO PHARMA LTD
LAMIVUDINE AND ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE 150MG;300MG TABLET;ORAL Prescription No AB 077411 CIPLA
LAMIVUDINE AND ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE 150MG;300MG TABLET;ORAL Prescription No AB 079124 HETERO LABS LTD III
LAMIVUDINE AND ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE 150MG;300MG TABLET;ORAL Prescription No AB 203259 HETERO LABS LTD V
LAMIVUDINE AND ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE 150MG;300MG TABLET;ORAL Prescription No AB 090246 LUPIN LTD
LAMIVUDINE AND ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE 150MG;300MG TABLET;ORAL Prescription No AB 090679 MACLEODS PHARMS LTD
LAMIVUDINE AND ZIDOVUDINE LAMIVUDINE; ZIDOVUDINE 150MG;300MG TABLET;ORAL Prescription No AB 079128 STRIDES PHARMA
بخوانید  CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY از شرکت NOVEL LABS INC
برچسب‌ها:

نظرات کاربران